Literature DB >> 26073396

Adolescent and adult African Americans have similar metabolic dyslipidemia.

Samuel S Gidding1, Scott W Keith2, Bonita Falkner3.   

Abstract

BACKGROUND: African Americans (AAs) have lower triglyceride (TG) and higher high-density lipoprotein cholesterol (HDL-C) than other ethnic groups; yet, they also have higher risk for developing diabetes mellitus despite the strong relationship of dyslipidemia with insulin resistance. No studies directly compare adolescents and adults with regard to relationships among dyslipidemia, high-sensitivity C-reactive protein (hs-CRP), and insulin resistance. Here, we compare AA adolescents to adults with regard to the relationships of adiposity-related lipid risk markers (TG-to-HDL ratio and non-HDL-C) with body mass index (BMI), waist circumference (WC), homeostasis model of insulin resistance (HOMA), and hs-CRP.
METHODS: Two cohorts of healthy AA were recruited from the same urban community. Participants in each cohort were stratified by TG-to-HDL ratio (based on adult tertiles) and non-HDL-C levels. BMI, WC, HOMA, and hs-CRP were compared in adolescents and adults in the low-, middle-, and high-lipid strata.
RESULTS: Prevalence of TG-to-HDL ratio greater than 2.028 (high group) was 16% (44 of 283) in adolescents and 33% (161 of 484) in adults; prevalence of non-HDL-C above 145 and 160, respectively, was 8% (22 of 283) in adolescents and 12% (60 of 484) in adults. Values of hs-CRP were lower, and HOMA values were higher in adolescents (both P < .01). As both TG-to-HDL ratio and non-HDL-C strata increased, BMI, WC, HOMA, and hs-CRP increased in both adolescents and adults. In the high TG-to-HDL ratio and non-HDL-C groups, BMI and WC were similar in adolescents vs adults (BMI, 34 kg/m(2) vs 32 kg/m(2); WC, 101 cm vs 101 cm). After adjusting for non-HDL-C and other covariates, a 2-fold increase in TG-to-HDL ratio was associated with increases of 10.4% in hs-CRP (95% CI, 1.1%-20.5%) and 24.2% in HOMA (95% CI, 16.4%-32.6%). Non-HDL-C was not significant in models having TG-to-HDL ratio.
CONCLUSION: The elevated TG-to-HDL ratio is associated with similar inflammation and metabolic risk relationships in adolescent and adult AAs.
Copyright © 2015 National Lipid Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HDL cholesterol; Inflammation; Insulin resistance; Obesity; Risk factors; Triglycerides

Mesh:

Substances:

Year:  2014        PMID: 26073396      PMCID: PMC4468785          DOI: 10.1016/j.jacl.2014.11.010

Source DB:  PubMed          Journal:  J Clin Lipidol        ISSN: 1876-4789            Impact factor:   4.766


  45 in total

1.  Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease?

Authors:  Tracey McLaughlin; Gerald Reaven; Fahim Abbasi; Cindy Lamendola; Mohammed Saad; David Waters; Joel Simon; Ronald M Krauss
Journal:  Am J Cardiol       Date:  2005-08-01       Impact factor: 2.778

2.  Ethnic differences in the ability of triglyceride levels to identify insulin resistance.

Authors:  Anne E Sumner; Catherine C Cowie
Journal:  Atherosclerosis       Date:  2007-01-24       Impact factor: 5.162

Review 3.  Racial and ethnic differences in cardiovascular disease risk factors: a systematic review.

Authors:  Anita K Kurian; Kathryn M Cardarelli
Journal:  Ethn Dis       Date:  2007       Impact factor: 1.847

4.  Usefulness of childhood non-high density lipoprotein cholesterol levels versus other lipoprotein measures in predicting adult subclinical atherosclerosis: the Bogalusa Heart Study.

Authors:  Maria G Frontini; Sathanur R Srinivasan; Jihua Xu; Rong Tang; M Gene Bond; Gerald S Berenson
Journal:  Pediatrics       Date:  2008-05       Impact factor: 7.124

5.  Utility of childhood non-high-density lipoprotein cholesterol levels in predicting adult dyslipidemia and other cardiovascular risks: the Bogalusa Heart Study.

Authors:  Sathanur R Srinivasan; Maria G Frontini; Jihua Xu; Gerald S Berenson
Journal:  Pediatrics       Date:  2006-07       Impact factor: 7.124

6.  Epidemiology, heritability, and genetic linkage of C-reactive protein in African Americans (from the Jackson Heart Study).

Authors:  Ervin R Fox; Emelia J Benjamin; Daniel F Sarpong; Charles N Rotimi; James G Wilson; Michael W Steffes; Guanjie Chen; Adebowale Adeyemo; Jason K Taylor; Tandaw E Samdarshi; Herman A Taylor
Journal:  Am J Cardiol       Date:  2008-07-25       Impact factor: 2.778

7.  Use of markers of dyslipidemia to identify overweight youth with insulin resistance.

Authors:  Tamara S Hannon; Fida Bacha; So Jung Lee; Janine Janosky; Silva A Arslanian
Journal:  Pediatr Diabetes       Date:  2006-10       Impact factor: 4.866

8.  Plasma lipid concentrations in nondiabetic African American adults: associations with insulin resistance and the metabolic syndrome.

Authors:  Elizabeth Stein; Harvey Kushner; Samuel Gidding; Bonita Falkner
Journal:  Metabolism       Date:  2007-07       Impact factor: 8.694

Review 9.  Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome.

Authors:  Martin Adiels; Sven-Olof Olofsson; Marja-Riitta Taskinen; Jan Borén
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-07       Impact factor: 8.311

10.  Does the association of the triglyceride to high-density lipoprotein cholesterol ratio with fasting serum insulin differ by race/ethnicity?

Authors:  Chaoyang Li; Earl S Ford; Yuan-Xiang Meng; Ali H Mokdad; Gerald M Reaven
Journal:  Cardiovasc Diabetol       Date:  2008-02-28       Impact factor: 9.951

View more
  2 in total

1.  Comparison of the HEI and HEI-2010 Diet Quality Measures in Association with Chronic Disease Risk among Low-Income, African American Urban Youth in Baltimore, Maryland.

Authors:  Margaret M Wrobleski; Elizabeth A Parker; Kristen M Hurley; Sarah Oberlander; Brian C Merry; Maureen M Black
Journal:  J Am Coll Nutr       Date:  2018-01-09       Impact factor: 3.169

Review 2.  Hypertriglyceridemia in Diabetes Mellitus: Implications for Pediatric Care.

Authors:  Jacob C Hartz; Sarah de Ferranti; Samuel Gidding
Journal:  J Endocr Soc       Date:  2018-05-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.